Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

International consensus study of antipsychotic dosing.

Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ.

Am J Psychiatry. 2010 Jun;167(6):686-93. doi: 10.1176/appi.ajp.2009.09060802. Epub 2010 Apr 1.

PMID:
20360319
2.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

3.

Optimal dosing of atypical antipsychotics in adults: a review of the current evidence.

Citrome L, Volavka J.

Harv Rev Psychiatry. 2002 Sep-Oct;10(5):280-91. Review.

PMID:
12202454
4.

Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.

Woods SW, Gueorguieva RV, Baker CB, Makuch RW.

Arch Gen Psychiatry. 2005 Sep;62(9):961-70. Review.

PMID:
16143728
5.

Practical guidelines for the use of new generation antipsychotic drugs (except clozapine) in adult individuals with intellectual disabilities.

de Leon J, Greenlee B, Barber J, Sabaawi M, Singh NN.

Res Dev Disabil. 2009 Jul-Aug;30(4):613-69. doi: 10.1016/j.ridd.2008.10.010. Epub 2008 Dec 11. Review.

PMID:
19084370
6.

Clinical guideline recommendations for antipsychotic long-acting injections.

Kane JM, Garcia-Ribera C.

Br J Psychiatry Suppl. 2009 Nov;52:S63-7. doi: 10.1192/bjp.195.52.s63. Review.

PMID:
19880920
7.

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.

Houthoofd SA, Morrens M, Sabbe BG.

Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Review.

PMID:
18840365
8.

Optimal dosing with risperidone: updated recommendations.

Williams R.

J Clin Psychiatry. 2001 Apr;62(4):282-9. Review.

PMID:
11379843
9.

Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophrenia.

Gopal S, Gassmann-Mayer C, Palumbo J, Samtani MN, Shiwach R, Alphs L.

Curr Med Res Opin. 2010 Feb;26(2):377-87. doi: 10.1185/03007990903482772. Review.

PMID:
20001492
10.

Effective dosing and dose equivalency of second-generation antipsychotic medications.

Buckley PF.

CNS Spectr. 2004 Sep;9(9 Suppl 9):24-31. Review.

PMID:
15361809
11.

Home treatment for mental health problems: a systematic review.

Burns T, Knapp M, Catty J, Healey A, Henderson J, Watt H, Wright C.

Health Technol Assess. 2001;5(15):1-139. Review.

12.

Therapeutic drug monitoring of antipsychotics.

Perry PJ.

Psychopharmacol Bull. 2001 Summer;35(3):19-29. Review.

PMID:
12397876
13.

Guidelines for the dosage of neuroleptics. II: Changing from daily oral to long acting injectable neuroleptics.

Schulz P, Rey MJ, Dick P, Tissot R.

Int Clin Psychopharmacol. 1989 Apr;4(2):105-14. Review.

PMID:
2568377
14.

The Expert Consensus Guideline Series. Treatment of behavioral emergencies.

Allen MH, Currier GW, Hughes DH, Reyes-Harde M, Docherty JP; Expert Consensus Panel for Behavioral Emergencies.

Postgrad Med. 2001 May;(Spec No):1-88; quiz 89-90. Review.

PMID:
11500996
15.

[Optimal Antipsychotic Dose and Dosing Interval in the Treatment of Schizophrenia].

Takeuchi H.

Seishin Shinkeigaku Zasshi. 2015;117(7):562-7. Review. Japanese.

PMID:
26552322
16.

Atypical antipsychotic dosing: the effect of smoking and caffeine.

de Leon J.

Psychiatr Serv. 2004 May;55(5):491-3. Review. No abstract available.

PMID:
15128955
17.

Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics.

Rey MJ, Schulz P, Costa C, Dick P, Tissot R.

Int Clin Psychopharmacol. 1989 Apr;4(2):95-104. Review.

PMID:
2568378
18.

Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review.

Taylor D.

Br J Psychiatry Suppl. 2009 Nov;52:S13-9. doi: 10.1192/bjp.195.52.s13. Review.

PMID:
19880912
19.

Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders.

Quraishi S, David A.

Cochrane Database Syst Rev. 2000;(2):CD001470. Review. Update in: Cochrane Database Syst Rev. 2014;6:CD001470.

PMID:
10796442
20.

Supplemental Content

Support Center